Evidence

Phase II is not a license. It is a map.

No large phase III has established BAT as standard of care. The signal is consistent enough — activity, resensitization, often better quality of life — that men and their doctors now argue about sequencing, not existence. Below is every trial named in the book, plus the core published results.